In current study, we have demonstrated that SA improves glucose metabolism disorder via the regulation of PI3K/Akt pathway and intestinal microbiota -mediated glycogen synthesis and glucose metabolism in HFD/STZ-induced T2DM mice. The gene discussed is AKT1; the disease is glucose metabolic process.